Jill Koshiol
Jill Koshiol is a renowned epidemiologist and cancer researcher currently working at the National Cancer Institute (NCI). She is particularly known for her extensive research on hepatocellular carcinoma (HCC), the most common type of liver cancer, and its association with infectious diseases.
Early Life and Education[edit | edit source]
Jill Koshiol was born and raised in the United States. She pursued her undergraduate studies in biology and later obtained her PhD in epidemiology. Her academic journey instilled in her a deep interest in cancer epidemiology, which she has pursued throughout her career.
Career[edit | edit source]
Koshiol began her career as a researcher at the National Cancer Institute, where she focused on the epidemiology of gastrointestinal cancers. Her work primarily involves studying the risk factors and prevention strategies for these types of cancers.
One of her significant contributions to the field is her research on hepatocellular carcinoma (HCC). Koshiol's work has shed light on the association between HCC and infectious diseases, particularly hepatitis B and hepatitis C. Her research has also explored the role of environmental factors and genetic predisposition in the development of HCC.
Research[edit | edit source]
Koshiol's research has significantly contributed to the understanding of the etiology of hepatocellular carcinoma. Her studies have shown that infectious diseases such as hepatitis B and C can increase the risk of developing HCC. Furthermore, her research has highlighted the importance of early detection and prevention strategies in managing this type of cancer.
Recognition[edit | edit source]
In recognition of her contributions to the field of cancer epidemiology, Koshiol has received numerous awards and accolades. She is also a frequent speaker at international conferences and symposiums, where she shares her insights and findings with the global scientific community.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD